Opinion|Videos|August 19, 2024
Harnessing Raw CGM Data for Personalized Diabetes Management
Author(s)Sean M. Oser, MD, MPH
Sean M. Oser, MD, MPH, discusses how raw CGM data can personalize diabetes treatment.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How can healthcare providers leverage the raw CGM mean glucose data directly, rather than relying on GMI, to gain deeper insights into a patient's glycemic control and optimize their diabetes management?
Advertisement
Related to this article
Onswik is approved to improve glycemic control in adults with Type 2 diabetes and will be available in the United States in the coming months in two concentrations. No information is available on the list price.
UCLA research suggests that GLP-1 therapies may protect bone health in Type 2 diabetes patients.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: State PBM reform in 2026—What's new since spring
2
Final GLOBE drug model projects much smaller savings while 2027 Part D premiums split
3
New lean MASH mouse model could guide more targeted liver disease treatment in humans
4
Billing for lab tests, especially genetic tests, is a mess. Bill Kerr has ideas about how to clean it up.
5